These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3966884)

  • 1. Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
    Cortelli P; Sacquegna T; Albani F; Baldrati A; D'Alessandro R; Baruzzi A; Lugaresi E
    Arch Neurol; 1985 Jan; 42(1):46-8. PubMed ID: 3966884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
    Albani F; Riva R; Baldrati A; Cortelli P; Perucca E; Procaccianti G; Baruzzi A
    Int J Clin Pharmacol Res; 1984; 4(1):19-23. PubMed ID: 6469429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
    Von Bahr C; Hermansson J; Tawara K
    Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
    Wong L; Nation RL; Chiou WL; Mehta PK
    Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study.
    Baldrati A; Cortelli P; Procaccianti G; Gamberini G; D'Alessandro R; Baruzzi A; Sacquegna T
    Acta Neurol Scand; 1983 Mar; 67(3):181-6. PubMed ID: 6868956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma propranolol concentration and relief of essential tremor.
    Jefferson D; Jenner P; Marsden CD
    J Neurol Neurosurg Psychiatry; 1979 Sep; 42(9):831-7. PubMed ID: 501384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol plasma binding and serum lipids during chronic therapy in migraine patients.
    Albani F; Riva R; Cortelli P; Contin M; Baruzzi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):267-9. PubMed ID: 4008116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.
    Rosseel MT; Bogaert MG
    J Pharm Sci; 1981 Jun; 70(6):688-9. PubMed ID: 7252820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of propranolol and migraine prophylaxis.
    Gengo FM; Fagan SC; Kinkel WR; McHugh WB
    Arch Neurol; 1984 Dec; 41(12):1306-7. PubMed ID: 6497736
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine.
    Stensrud P; Sjaastad O
    Acta Neurol Scand; 1976 Mar; 53(3):229-32. PubMed ID: 773081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.
    Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
    Clin Pharmacol Ther; 1980 Jan; 27(1):22-31. PubMed ID: 7351114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of propranolol and 4-hydroxypropranolol in human plasma by high-performance liquid chromatography.
    Fu CW; Mason WD
    Analyst; 1989 Oct; 114(10):1219-23. PubMed ID: 2619067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1978 May; 145(3):429-36. PubMed ID: 659528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. IV. A rapid microscale method for determination of propranolol and 4-hydroxypropranolol in plasma.
    Sood SP; Green VI; Mason RP
    Ther Drug Monit; 1988; 10(2):224-30. PubMed ID: 3381242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of migraine with propranolol.
    Borgesen SE
    Postgrad Med J; 1976; 52 Suppl 4():163-5. PubMed ID: 787958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo administration of propranolol decreases exaggerated amounts of serum TNF-alpha in patients with migraine without aura. Possible mechanism of action.
    Covelli V; Munno I; Pellegrino NM; Marinaro MR; Gesario A; Massari F; Savastano S; Jirillo E
    Acta Neurol (Napoli); 1992; 14(4-6):313-9. PubMed ID: 1293974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in the treatment of acute migraine attacks.
    Banerjee M; Findley L
    Cephalalgia; 1991 Sep; 11(4):193-6. PubMed ID: 1742775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.